Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History
Pro Share Advisors LLC
- $36.7 Billion
- Q1 2024
A detailed history of Pro Share Advisors LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 33,281 shares of BBIO stock, worth $887,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,281
Previous 30,072
10.67%
Holding current value
$887,604
Previous $1.21 Million
15.24%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BBIO
# of Institutions
288Shares Held
170MCall Options Held
7.64MPut Options Held
2.15M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$828 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$670 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$279 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$162 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.95B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...